Syros Pharmaceuticals (NASDAQ:SYRS) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the stock. Several other research analysts have also weighed in on SYRS. Brookline Capital Management reaffirmed a “hold” rating on shares of Syros Pharmaceuticals in a research note on […]
16 Mar 06:32 · The Markets Daily